enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. AstraZeneca raises profit outlook on strong medicines demand

    www.aol.com/news/astrazeneca-raises-full-outlook...

    Sales in AstraZeneca's top business, oncology, grew 19% at constant currency rates to $5.33 billion and accounted for 41% of the total, while its rare disease and heart and kidney disease ...

  3. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

    The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca , [ 33 ] [ 34 ] [ 35 ] using as a vector the modified ...

  4. AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/AstraZeneca

    AstraZeneca plc ( / ˌæstrəˈzɛnəkə /) ( AZ) is a British-Swedish multinational pharmaceutical and biotechnology company [ 2][ 3][ 4] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. [ 5] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection ...

  5. Mene Pangalos - Wikipedia

    en.wikipedia.org/wiki/Mene_Pangalos

    Mene Pangalos. Sir Menelaos (Mene) Nicolas Pangalos ( Greek: Μενέλαος Νικόλας Πάγκαλος) is a British neuroscientist of Greek descent. Pangalos is Executive Vice President, BioPharmaceuticals R&D at AstraZeneca. [ 1] He is responsible for the company's research and development of new drugs to treat respiratory ...

  6. Here's What AstraZeneca's CEO Has to Say About the ... - AOL

    www.aol.com/finance/heres-astrazenecas-ceo...

    In that vein, AstraZeneca's ... in practice the side effects of treatment lead to high cessation rates. ... Stock Advisor provides investors with an easy-to-follow blueprint for success, ...

  7. AstraZeneca CFO: 'We've come a long way in our oncology ...

    www.aol.com/finance/astrazeneca-cfo-weve-come...

    AstraZeneca has long been in the oncology and other disease spaces, but rose to popularity in recent years with the success of its COVID-19 vaccine.The company has since withdrawn the vaccine due ...

  8. History of COVID-19 vaccine development - Wikipedia

    en.wikipedia.org/wiki/History_of_COVID-19...

    SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. [ 1] Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. [ 2][ 3][ 4] Since 2020, vaccine ...

  9. AstraZeneca antibody cocktail study shows success treating ...

    www.aol.com/news/astrazeneca-drug-cocktail...

    (Reuters) -AstraZeneca's antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, was also shown to save lives and prevent severe disease when given ...